Cardinal Health (NYSE: CAH) closed yesterday at $34.18. So far the stock has hit a 52-week low of $27.79 and 52-week high of $62.25. The proprietary Key Risk Ranking for CAH has improved fr...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
Cardinal Health (NYSE: CAH) closed yesterday at $33.09. So far the stock has hit a 52-week low of $27.79 and 52-week high of $62.25. The proprietary Key Risk Ranking for CAH has improved fr...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
Cardinal Health (NYSE: CAH) closed yesterday at $32.74. So far the stock has hit a 52-week low of $27.79 and 52-week high of $62.25. The proprietary Key Risk Ranking for CAH has improved fr...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
Cardinal Health (NYSE: CAH) closed yesterday at $34.35. So far the stock has hit a 52-week low of $27.79 and 52-week high of $62.25. The proprietary Key Risk Ranking for CAH has improved fr...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
NitroMed (NDAQ: NTMD) buyout offer from Archemix received some opposition from an activist hedge fund. Deerfield Partners said that the merger overvalues Archemix and contains numerous conflicts of interest. Moreover, Deerfield, which holds a 12% stake, offered to acquire the company for $0.50 a share, liquidate the company and distribute the proceeds to shareholders. This would represent a substantially higher value than the current offer on the table. The majority of NitroMed’s value can be found in its $17.8 million in cash, equivalents and short-term investments as of September 30th. The company also stands to get an additional $26.3 million from the pending sale of heart failure drug BilDil, which was approved for African-American patients in 2005 but never gained significant market share. Assuming these sales, NitroMed would have about $44[More...]
Money managers clean up portfolio holdings before the end of their tax year. Over 48% of US mutual funds close their books between late October and December. Managers sell stocks with large losses to avoid reporting them on their year-end report to shareholders. This causes downward pressure on stocks trading within ...
Earnings were mixed on Wednesday and outlook of the firms in individual industry remain weak amid slumping credit market condition and higher expenses.[More...]